Stay updated on Long-Term Follow-Up of Dupilumab Safety in Asthma Clinical Trial
Sign up to get notified when there's something new on the Long-Term Follow-Up of Dupilumab Safety in Asthma Clinical Trial page.

Latest updates to the Long-Term Follow-Up of Dupilumab Safety in Asthma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page has undergone significant updates, including the removal of detailed information about a clinical trial for dupilumab in asthma and the addition of a new version revision. The collaborators' information remains consistent, but the core content regarding the study's objectives and participant criteria has been deleted.SummaryDifference8%
- Check42 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check49 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check85 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check100 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact for assistance.SummaryDifference1%
Stay in the know with updates to Long-Term Follow-Up of Dupilumab Safety in Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-Term Follow-Up of Dupilumab Safety in Asthma Clinical Trial page.